About Adaptyv Biosystems
Adaptyv Biosystems is a company based in Lausanne (Switzerland) founded in 2021 by Daniel Nakhaee Zadeh Gutierrez, Moustafa Houmani, and Julian Englert. Adaptyv Biosystems has raised $2.63 million across 4 funding rounds from investors including Axial, Acequia Capital and FAST. Adaptyv Biosystems offers products and services including Cloud Lab and API. Adaptyv Biosystems operates in a competitive market with competitors including Rheonix, Phoremost, 64x Bio, Nanna Therapeutics and reMYND, among others.
- Headquarter Lausanne, Switzerland
- Founders Daniel Nakhaee Zadeh Gutierrez, Moustafa Houmani, Julian Englert
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Adaptyv Biosystems Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.63 M (USD)
in 4 rounds
-
Latest Funding Round
$2.5 M (USD), Seed
Feb 14, 2022
-
Investors
Axial
& 11 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Adaptyv Biosystems
Adaptyv Biosystems offers a comprehensive portfolio of products and services, including Cloud Lab and API.
AI platform for generating and testing protein designs in biotechnology.
Interface for protein experimentation and data generation tools.
People of Adaptyv Biosystems
Unlock access to complete
Funding Insights of Adaptyv Biosystems
Adaptyv Biosystems has successfully raised a total of $2.63M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $2.5 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Adaptyv Biosystems
Adaptyv Biosystems has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Axial, Acequia Capital and FAST.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in early-stage tech companies by Acequia Capital.
|
Locked | Locked | Locked | |
|
Student-led venture capital fund supporting Swiss student startups.
|
Locked | Locked | Locked | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked |
Investor details for Adaptyv Biosystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Adaptyv Biosystems
Investment portfolio details for Adaptyv Biosystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Adaptyv Biosystems
Detailed financials for Adaptyv Biosystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adaptyv Biosystems Comparisons
Peer comparison for Adaptyv Biosystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Adaptyv Biosystems
Adaptyv Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rheonix, Phoremost, 64x Bio, Nanna Therapeutics and reMYND, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instruments for automated molecular assays are developed using disposable cartridges.
|
|
| Locked | Locked | Locked |
Phenotypic screening platform developed to identify drug targets and pathways.
|
|
| Locked | Locked | Locked |
Cell and gene therapies for multiple diseases are developed.
|
|
| Locked | Locked | Locked |
In-vitro directed evolution platform is provided for drug discovery.
|
|
| Locked | Locked | Locked |
Developer of a drug pipeline programs for neurodegenerative diseases
|
Detailed competitors of Adaptyv Biosystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adaptyv Biosystems
Complete news archive for Adaptyv Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adaptyv Biosystems
Adaptyv Biosystems was founded in 2021.
Adaptyv Biosystems is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Adaptyv Biosystems is a funded company, having raised a total of $2.63M across 4 funding rounds to date.
Founded in 2021 and based in Lausanne, Switzerland, operations in the biotechnology sector are conducted by Adaptyv Biosystems. Protein design, synthesis, testing, and validation services are provided through an integrated platform. Experimental data is generated to refine protein designs, while protein expression is streamlined and synthesis of custom proteins is enabled. Automated workcells are utilized to profile designs for functional and interactive properties.
Adaptyv Biosystems offers Cloud Lab and API.
Adaptyv Biosystems has 12 investors. Key investors include Axial, Acequia Capital, FAST, Founders, and Founderful Campus.